TY - JOUR
T1 - Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry
T2 - Potential for diagnostic applications
AU - Fetsch, Patricia A.
AU - Simone, Nicole L.
AU - Bryant-Greenwood, Peter K.
AU - Marincola, Francesco M.
AU - Filie, Armando C.
AU - Petricoin, Emmanuel F.
AU - Liotta, Lance A.
AU - Abati, Andrea
PY - 2002/12/1
Y1 - 2002/12/1
N2 - Proteomic studies of cells via surface-enhanced laser desorption/ ionization spectrometry (SELDI) analysis have enabled rapid, reproducible protein profiling directly from crude samples. We applied this technique to archival cytology material to determine whether distinct, reproducible protein fingerprints could be identified for potential diagnostic purposes in blinded specimens. Rapid Romanowsky-stained cytocentrifuged specimens from fine-needle aspirates of metastatic malignant melanoma (with both known cutaneous primary and unknown primary sites), clear cell sarcoma, and renal cell carcinoma and reactive effusions were examined using the SELDI technology. A unique characteristic fingerprint was identified for each disease entity. Fifteen "blinded" unknown samples then were analyzed. When the protein profile fingerprints were plotted against the known fingerprints for the aforementioned diagnoses, the appropriate match or diagnosis was obtained in 13 (87%) of 15 cases. These preliminary findings suggest a substantial potential for SELDI applications to specific pathologic diagnoses.
AB - Proteomic studies of cells via surface-enhanced laser desorption/ ionization spectrometry (SELDI) analysis have enabled rapid, reproducible protein profiling directly from crude samples. We applied this technique to archival cytology material to determine whether distinct, reproducible protein fingerprints could be identified for potential diagnostic purposes in blinded specimens. Rapid Romanowsky-stained cytocentrifuged specimens from fine-needle aspirates of metastatic malignant melanoma (with both known cutaneous primary and unknown primary sites), clear cell sarcoma, and renal cell carcinoma and reactive effusions were examined using the SELDI technology. A unique characteristic fingerprint was identified for each disease entity. Fifteen "blinded" unknown samples then were analyzed. When the protein profile fingerprints were plotted against the known fingerprints for the aforementioned diagnoses, the appropriate match or diagnosis was obtained in 13 (87%) of 15 cases. These preliminary findings suggest a substantial potential for SELDI applications to specific pathologic diagnoses.
KW - Archival cytologic samples
KW - Clear cell sarcoma
KW - Melanoma
KW - Protein biochip
KW - Protein fingerprint
KW - Proteomics
KW - Reactive mesothelial cells
KW - Renal cell carcinoma
KW - SELDI
UR - http://www.scopus.com/inward/record.url?scp=0036883978&partnerID=8YFLogxK
U2 - 10.1309/EJKL-7328-KFPR-56WA
DO - 10.1309/EJKL-7328-KFPR-56WA
M3 - Article
C2 - 12472280
AN - SCOPUS:0036883978
SN - 0002-9173
VL - 118
SP - 870
EP - 876
JO - American Journal of Clinical Pathology
JF - American Journal of Clinical Pathology
IS - 6
ER -